Coherus Biosciences | CHRS - Capitalisation Boursière

Prix De L'Action
1.52
Variation Quotidienne
-0.09 -5.59%
Mensuellement
-6.17%
Annuel
47.57%
Q1 Prévisions
1.47




Capitalisation Boursière Changement Date
AbbVie USD 403.83B 5.2B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Akebia Therapeutics USD 312M 115M 2026-03
ALKERMES USD 4.47B 146M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 308M 18M 2026-03
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 183M 11M 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Fujifilm JPY 3.67T 362.61B 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
Merck USD 261.26B 51.62B 2025-12
Myriad Genetics USD 417M 158M 2026-03
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.4B 520M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12
Zoetis USD 55.45B 9.4B 2025-12